Receptor-activity modifying protein 1 expression is increased in the striatum following repeated L-DOPA administration in a 6-hydroxydopamine lesioned rat model of Parkinson's disease. [electronic resource]
Producer: 20080603Description: 310-3 p. digitalISSN:- 0887-4476
- Adrenergic Agents -- toxicity
- Animals
- Corpus Striatum -- drug effects
- Disease Models, Animal
- Dopamine Agents -- pharmacology
- Dyskinesia, Drug-Induced -- physiopathology
- Gene Expression
- In Situ Hybridization
- Intracellular Signaling Peptides and Proteins
- Levodopa -- pharmacology
- Membrane Proteins -- biosynthesis
- Motor Activity -- drug effects
- Oxidopamine -- toxicity
- Parkinsonian Disorders -- drug therapy
- RNA, Messenger -- analysis
- Rats
- Rats, Sprague-Dawley
- Receptor Activity-Modifying Protein 1
- Receptor Activity-Modifying Proteins
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.